fda warning letters glp-1 october 2025 news Why the Issued 30 to Telehealth Sites Marketing Compounded GLP-1s GLP‑1 Compliance: FDA Targets Telehealth
Description
The mean differences in A1c and body weight between IDegLira and basalbolus therapy and IDeglira and basal glargine were 0.3% and 6.89 kg and 0.65% and 4.04 kg respectively
/Passle/67196104ea6deed3d1072b7a/SearchServiceImages/2026-03-12-15-29-25-571-69b2dbd5401a85d306661348.jpg)
In this case, it seems to be the 65/20 rule for processed food and drink

In parallel, emerging data from male reproductive studies suggest that GLP-1RAs may positively influence the hypothalamic-pituitarytesticular axis, improve testicular function, and enhance spermatogenesis, particularly in obese men

Bibliografia Koye DN, Shaw JE, Reid CM, et al

People with diabetes, particularly severe diabetes, tend to lose less weight with GLP-1s than people without diabetes, so microdosing is less likely to be as effective, though their dose should only be increased as they tolerate it. George said that in her professional opinion, microdosing is a potential option for patients with smaller amounts of weight to lose or as a bridge to start, or wean off, regular GLP-1 medications

Focus on complete proteins: eggs, fish, poultry, dairy, or plant-based alternatives with complete amino acid profiles
